Milestone · Healthcare & Life Sciences

Bibo Health remains profitable and bootstrapped

By Startup Enthusiast · 18 June 2026

What they do

Bibo Health sells over-the-counter respiratory products for sinusitis and asthma

The company is bootstrapped and has been profitable for more than 18 months

It plans to launch an obesity management program and expand into gastro care

Bibo Health operates as a bootstrapped consumer health brand in India.
The company achieved profitability for over 18 months without external funding.
Founders decided against raising funds for the next two years.
The business pivoted from offline pharmacies to online quick commerce platforms.
Current operations focus on maintaining profitability rather than aggressive expansion.
The team downsized operations during 2023-24 to sustain financial health.
Marketing relies heavily on content-first strategies and doctor interviews.
The brand maintains a strong presence on major e-commerce marketplaces.

Bootstrapping allows founders to retain full control over company decisions.
Profitability demonstrates sustainable unit economics in the competitive D2C space.
Avoiding dilution preserves equity for future strategic opportunities.

Bibo Health sells OTC products for chronic breathing disorders like asthma.
The product range includes nasal sprays and holistic self-care items.
Distribution occurs via quick commerce apps like Blinkit and JioMart.
The brand also sells through major marketplaces like Amazon and Flipkart.
Products are available across 40 cities in India.
The website conversion rate stands at approximately 7 percent.
Marketing utilizes long-form articles and YouTube videos with ENT specialists.
The brand name Bibo stands for Breath in breath out.
The company started with five products and expanded its portfolio.

ah!Ventures (lead) — Angel investor group that provided initial funding.
SR Innovation Exchange (co-lead) — Provided funding alongside ah!Ventures in 2022.